Filing Flows › Eton Pharmaceuticals (ETON) › Net income
Eton Pharmaceuticals (ETON) net income by quarter
Eton Pharmaceuticals' net income was $35.2M in Q3 2026 (third quarter 2026), +204% from Q2 2026. Over the last 4 quarters it ranged from $1.5M (Q4 2025) to $35.2M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $35.2M | +204% | — |
| Q2 2026 | $11.6M | +645% | — |
| Q1 2026 | $1.6M | +5% | — |
| Q4 2025 | $1.5M | — | — |
Q3 2026 at a glance
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Eton Pharmaceuticals' net income?
Eton Pharmaceuticals' net income was $35.2M in Q3 2026 (third quarter 2026), +204% from Q2 2026.
How has Eton Pharmaceuticals' net income changed?
Over the last 4 quarters it ranged from $1.5M (Q4 2025) to $35.2M (Q3 2026).